Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Nifty Pharma Index Fund
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct) and ICICI Prudential Nifty Pharma Index Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Index Funds schemes — see the best index funds for the full ranking.
Head to head
NAVs as of 12 Nov 2026
Growth of ₹100 (rebased over the selected window)
Common period 15 Dec 2022 – 12 Nov 2026, limited by ICICI Prudential Nifty Pharma Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund | ICICI Prudential Nifty Pharma Index Fund | Nifty Pharma TRI |
|---|---|---|---|
| 15 Dec 2022 | ₹100.00 | ₹100.00 | ₹100.00 |
| 13 Apr 2023 | ₹97.82 | ₹97.54 | ₹97.71 |
| 10 Aug 2023 | ₹114.61 | ₹121.22 | ₹122.38 |
| 07 Dec 2023 | ₹119.59 | ₹126.49 | ₹128.35 |
| 04 Apr 2024 | ₹137.63 | ₹148.41 | ₹151.01 |
| 01 Aug 2024 | ₹153.78 | ₹168.93 | ₹172.41 |
| 28 Nov 2024 | ₹154.68 | ₹168.37 | ₹172.26 |
| 27 Mar 2025 | ₹154.09 | ₹165.10 | ₹169.02 |
| 24 Jul 2025 | ₹162.01 | ₹175.20 | ₹179.47 |
| 20 Nov 2025 | ₹168.74 | ₹176.44 | ₹181.06 |
| 19 Mar 2026 | ₹163.77 | ₹171.97 | ₹176.77 |
| 16 Jul 2026 | ₹191.80 | ₹202.43 | ₹208.48 |
| 12 Nov 2026 | ₹206.12 | ₹223.28 | ₹230.28 |
Portfolio overlap (same stocks held through more than one fund)
Some overlap is structural: SEBI defines large cap as the top 100 stocks by market capitalisation, so two large-cap funds are fishing the same pond by regulation. The bands below are measured per sleeve pairing rather than against one blanket threshold. How this is measured →
- 28 stocks only in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
- 16 stocks in both — 52.4% of each portfolio by weight
- 4 stocks only in ICICI Prudential Nifty Pharma Index Fund
The more the circles overlap, the more the funds hold the same stocks.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund and ICICI Prudential Nifty Pharma Index Fund duplicate 52% of their equity book — holding both adds concentration, not diversification.
Shared holdings — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Nifty Pharma Index Fund
| Stock | Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund | ICICI Prudential Nifty Pharma Index Fund | |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.00% | 18.62% | 11.00% |
| Divi's Laboratories Ltd. | 6.97% | 12.29% | 6.97% |
| Torrent Pharmaceuticals Ltd. | 4.45% | 6.71% | 4.45% |
| Cipla Ltd. | 4.38% | 7.67% | 4.38% |
| Laurus Labs Ltd. | 4.14% | 9.27% | 4.14% |
| Dr. Reddy's Laboratories Ltd. | 3.56% | 8.15% | 3.56% |
| Lupin Ltd. | 3.08% | 4.83% | 3.08% |
| Aurobindo Pharma Ltd. | 2.76% | 4.60% | 2.76% |
| Glenmark Pharmaceuticals Ltd. | 2.15% | 3.42% | 2.15% |
| IPCA Laboratories Ltd. | 1.70% | 2.65% | 1.70% |
| Biocon Ltd. | 1.64% | 2.42% | 1.64% |
| Mankind Pharma Ltd. | 1.54% | 2.79% | 1.54% |
| Alkem Laboratories Ltd. | 1.37% | 3.05% | 1.37% |
| Zydus Lifesciences Ltd. | 1.33% | 3.05% | 1.33% |
| Gland Pharma Ltd. | 1.32% | 2.44% | 1.32% |
1 more stocks in common. 16 shared of 44 / 20 positions. Weights are shown as a share of each fund's equity book.
What differs, in plain wordsAI
| Metric | Edelweiss · Direct NAV ₹26.14 Very High risk Unrated | ICICI Prudential · Direct NAV ₹22.20 Very High risk ★★★★★ |
|---|---|---|
| +22.77% | +27.06%Best in row | |
| +21.83% | +22.76%Best in row | |
| +15.76% | — | |
| +17.30% | +22.81% | |
| +19.74% | — | |
| +17.48% | +22.04%Best in row | |
| +14.04% | — | |
| Risk | ||
| 11.88%Best in row | 15.32% | |
| 1.29Best in row | 1.06 | |
| 1.87Best in row | 1.55 | |
| -16.31% | -16.59% | |
| — | Nifty Pharma TRI | |
| — | -0.65% | |
| — | 1.00 | |
| — | 99.1% | |
| — | 102.2% | |
| 0.55% | 0.51%Best in row | |
| ₹195.18Cr | ₹150.77Cr | |
| ₹100 | ₹1.00K | |
| ₹100 | ₹1.00K | |
| — | 24% | |
| Bhavesh Jain · 5.1y | Nishit Patel | |
| 26 Oct 2020 | 14 Dec 2022 | |
| 44 | 20 | |
| 55.2% | 78.5% | |
5 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Exit load
- None
- Lock-in
- None
- Cash & equivalents
- 0.1%
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Over the last 3 years, ICICI Prudential Nifty Pharma Index Fund returned +22.76% CAGR against Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund's +21.83%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has the lower expense ratio: Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund charges 0.55% a year against ICICI Prudential Nifty Pharma Index Fund's 0.51%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has shown higher volatility (+15.32% annualized vs Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund's +11.88%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -12.15% vs ICICI Prudential Nifty Pharma Index Fund -16.59%.
Which fund manages more money — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is the larger fund: Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund manages ₹195.18Cr against ICICI Prudential Nifty Pharma Index Fund's ₹150.77Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund and ICICI Prudential Nifty Pharma Index Fund in the same category?
Yes — both are Index Funds schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.